Ken Anderson is a senior advisor at Dial Partners LLP, with over 30 years’ experience in a variety of industries, with particular emphasis on government services, healthcare and energy in the UK, US, Europe and the Middle East. 

In 2020, Ken was senior advisor to the Saudi Arabian Minister of Health, helping to design the new delivery model and implementation of the Saudi Healthcare Transformation Programme, Vision 2030. 

Previously Ken was Vice Chairman of UBS’s global health advisory advising among others GSK, HCA, Swedish Government, UK Government, Arcadia, Blackstone, Mubadala, TPG, Dell, and BP.  Prior to that Ken was Commercial Director General of the Department of Health and National Health Service initiating privatisation-based NHS reforms.

Ken is Adjunct Professor of Finance and Health Management at the Imperial College Business School, sits on the board of Texas A&M University’s Biotechnology Commercialisation Company and is Senior Advisor with Greenhill Investment Bank.